US med info body joins Euro federation

  • 23 August 2010

The American Health Information Management Association has been accepted as an institutional member of the European Federation for Medical Informatics.

The AHIMA is a health information management professional association that is dedicated to the effective management of health information.

The EFMI, which has 31 member countries, is a non profit organisation that aims to advance international cooperation in medical informatics in Europe as well as promoting high standards of medical information.

Robert Nelson, managing director of global operations at AHIMA, said: “Both AHIMA and EFMI are seriously working toward improving the current situation of medical informatics and the use of the technology at a European, and even global level.

“This formal relationship will facilitate continued and increased synergy between the work both organisations are doing.”

The acceptance follows a meeting between the two organisations that the Tenth EFMI Special Topic Conference 2010 in Reykjavik, Iceland, where they mapped out ideas for collaboration in seamless-safe care.

Links: EFMI 

AHIMA 

 

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

AI can help build sustainable services – but only if we mitigate its risks

AI can help build sustainable services – but only if we mitigate its risks

Concerns about AI should not stop progress. They should prompt us to think about how to apply such powerful processing, argue Rebecca Hughes and Paul…
Digital Health Coffee Time Briefing ☕

Digital Health Coffee Time Briefing ☕

Your morning summary of digital health news, information and events to know about if you want to be “in the know”. 👇  News 🧠 Cambridge…
NHS Greater Glasgow and Clyde trials tech for infant respiratory disorders

NHS Greater Glasgow and Clyde trials tech for infant respiratory disorders

A wireless device and software developed by NHS Greater Glasgow and Clyde’s West of Scotland Innovation Hub, is being trialled in young patients.